Startseite Crystal structure of 5-((4-(1H-benzo[d]imidazol-2-yl)-2-methoxyphenoxy)methyl)-2-chlorothiazole - trichloromethane - methanol (1/1/1), C20H19Cl4N3O3S
Artikel Open Access

Crystal structure of 5-((4-(1H-benzo[d]imidazol-2-yl)-2-methoxyphenoxy)methyl)-2-chlorothiazole - trichloromethane - methanol (1/1/1), C20H19Cl4N3O3S

  • An-Jia Wang , Yun-Hui Zhang , Zhi Zhang , Ai-Zhen Weng , Liu-Yang Wang , Dong-Mei She , Jun Ning , Wei-Jie Si und Xiang-Dong Mei EMAIL logo
Veröffentlicht/Copyright: 9. Februar 2018

Abstract

C20H19Cl4N3O3S, monoclinic, P21/c (no. 14), a = 14.2134(9) Å, b = 21.4083(13) Å, c = 7.6709(5) Å, β = 99.260(6)°, V = 2303.7(2) Å3, Z = 4, Rgt(F) = 0.0659, wRref(F2) = 0.1682, T = 180 K.

CCDC no.:: 1817198

Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Yellow block
Size:0.15 × 0.1 × 0.1 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.63 mm−1
Diffractometer, scan mode:XtaLAB Pro, ω-scans
2θmax, completeness:25°, >99%
N(hkl)measured, N(hkl)unique, Rint:21040, 4537, 0.035
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 4146
N(param)refined:287
Programs:CrysAlisPRO [1], SHELX [2], OLEX2 [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
S10.17167(6)0.18474(4)0.32197(11)0.0301(2)
Cl1−0.00451(7)0.10788(4)0.30692(12)0.0370(2)
Cl20.67863(11)0.28270(16)0.2568(2)0.1407(12)
Cl30.81331(16)0.34423(9)0.0764(3)0.1015(6)
Cl40.84389(11)0.33899(7)0.4571(2)0.0770(4)
O10.29934(15)0.30957(10)0.4898(3)0.0242(5)
O20.40726(16)0.30557(11)0.7963(3)0.0285(5)
O30.6467(3)0.47183(14)0.0945(3)0.0507(8)
N10.6898(2)0.46525(14)0.4646(4)0.0275(6)
N20.69270(18)0.45658(12)0.7559(3)0.0243(5)
N30.0034(2)0.23116(15)0.3072(5)0.0394(7)
C10.6452(2)0.44342(14)0.5975(4)0.0236(6)
C20.7727(2)0.49437(15)0.5415(4)0.0268(7)
C30.8449(3)0.52375(17)0.4703(5)0.0339(8)
C40.9206(2)0.54730(17)0.5902(5)0.0346(8)
C50.9229(2)0.54245(16)0.7718(5)0.0311(7)
C60.8502(2)0.51352(15)0.8423(4)0.0283(7)
C70.7737(2)0.48876(14)0.7238(4)0.0232(6)
C80.5538(2)0.40997(14)0.5636(4)0.0227(6)
C90.5268(2)0.37287(15)0.6984(4)0.0230(6)
C100.4410(2)0.34145(14)0.6716(4)0.0222(6)
C110.3807(2)0.34506(14)0.5060(4)0.0217(6)
C120.4072(2)0.38215(16)0.3744(4)0.0265(7)
C130.4931(2)0.41483(16)0.4032(4)0.0278(7)
C140.4668(3)0.30177(18)0.9655(4)0.0336(8)
C150.2421(2)0.30846(16)0.3163(4)0.0267(7)
C160.1611(2)0.26497(15)0.3189(4)0.0263(7)
C170.0661(2)0.27947(17)0.3129(6)0.0381(9)
C180.0498(2)0.17987(16)0.3136(4)0.0282(7)
C190.7976(3)0.3003(2)0.2607(6)0.0525(11)
C200.6277(4)0.5345(3)0.0790(6)0.0656(15)
H10.675(3)0.4587(18)0.365(6)0.026(10)*
H30.84290.52750.34900.041*
H3A0.66230.45890.00270.076*
H40.97080.56680.54780.042*
H50.97450.55900.84780.037*
H60.85210.51060.96370.034*
H90.56710.36950.80620.028*
H120.36740.38530.26600.032*
H130.50990.44010.31440.033*
H14A0.52420.27950.95420.050*
H14B0.43350.28011.04660.050*
H14C0.48260.34311.00890.050*
H15A0.28040.29470.22980.032*
H15B0.21840.35010.28410.032*
H170.04560.32070.31280.046*
H190.83250.26090.25700.063*
H20A0.62720.55200.19410.098*
H20B0.56670.54080.00710.098*
H20C0.67610.55470.02510.098*

Source of material

The title compound was prepared according to the literature method [3], [4], [5], [6]. A mixture of 2-(4-hydroxy-3-methoxyphenyl)-(1H)-benzimidazole (5 mmol), 2-chloro-5-chloromethylthiazole (7.5 mmol) and sodium hydroxide (10 mmol) in ethanol (25 mL) was refluxed for 2 h. Ethanol was evaporated and the residue was poured into ice cold water and extracted with ethyl acetate. The title compound was obtained by column chromatography. The title compound was dissolved in a mixed solvent of chloroform, methanol and petroleum ether at room temperature. Yellow blocks were obtained through slow evaporation after two weeks.

Experimental details

All hydrogen atoms were placed at calculated positions.

Discussion

The title compound, 5-((4-(1H-benzo[d]imidazol-2-yl)-2-methoxyphenoxy)methyl)-2-chlorothiazole and other benzimidazole derivatives are important antifungal candidates [7], [8], [9]. It is important to determine the structure of unknown synthetic compounds by X-ray single crystal diffraction before the study of the biological activity. The molecule consists of a substituted (1H)-benzimidazol ring and a 2-chloro thiazole moiety, both rings are connected by an aryl moiety. The asymmetric unit of the title compound contains one title molecules, one chloroform molecule and one methanol molecule. In the figure the sovent molecules are omitted for clarity.

Acknowledgements

This work was supported by the National Key Research Development Program of China (no. 2016YFD200201 and 2016YFD0200502) and the National Natural Science Foundation of China (no. 31772175 and no. 31321004), the National Basic Research Program of China (no. 2014CB932200).

References

Agilent Technologies: CrysAlisPro Software system, version 1.171.39.7e, Rigaku OD, (2015).Suche in Google Scholar

Sheldrick, G.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar PubMed PubMed Central

Dolomanov, O.; Bourhis, L.; Gildea, R.; Howard, J. A.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Suche in Google Scholar

Alpan, A.; Gunes, H.; Topcu, Z.: 1H-Benzimidazole derivatives as mammalian DNA topoisomerase I inhibitors. Acta. Biochim. Pol. 54 (2007) 561–565.10.18388/abp.2007_3229Suche in Google Scholar

Coban, G.; Zencir, S.; Zupko, I.; Rethy, B.; Gunes, S. H.; Topcu, Z.: Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assaysy. Eur. J. Med. Chem.44 (2009) 2280–2285.10.1016/j.ejmech.2008.06.018Suche in Google Scholar PubMed

Alpan, A.; Yilmaz, O.; Kilickaya, O.; Kara, P.: Synthesis and voltammetric detection of 1H-benzimidazole derivatives on the interaction with DNA. Mar. Pharm. J. 16 (2012) 48–55.10.12991/201216420Suche in Google Scholar

Akpa, S.; Zoakouma, R.; Say, V.; Ouattara, M.; Kone, M.; Sissouma, D.; Adjou, A.: Synthesis and in vitro antifungal evaluation of 2-thioalkylaryl-benzimidazoles derivatives against Candida albicans. Int. J. Biol. Chem. Sci. 10 (2016) 1403–1412.10.4314/ijbcs.v10i3.38Suche in Google Scholar

Chandrika, N.; Shrestha, S.; Ngo, H.; Garneau-Tsodikova, S.: Synthesis and investigation of novel benzimidazole derivatives as antifungal agents. Bioorg. Med. Chem. 24 (2016) 3680–3686.10.1016/j.bmc.2016.06.010Suche in Google Scholar PubMed PubMed Central

Keller, P.; Mueller, C.; Engelhardt, I.; Hiller, E.; Lemuth, K.; Eickhoff, H.; Rupp, S.: An antifungal benzimidazole derivative inhibits ergosterol biosynthesis and reveals novel sterols. Antimicrob. Agent. Ch. C59 (2015) 6296–6307.10.1128/AAC.00640-15Suche in Google Scholar PubMed PubMed Central

Received: 2017-10-10
Accepted: 2018-1-16
Published Online: 2018-2-9
Published in Print: 2018-3-28

©2018 An-Jia Wang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure and optical properties of diaqua-tris(nitrato-κ2O,O′)-bis(4,4,5,5-tetramethyl-2-(p-pyridyl)imidazoline-1-oxyl 3-oxide-κN)praseodymium(III), C24H36N9O15Pr
  3. Crystal structure of dimethanol-bis(μ2-methanol-κ2O:O)-bis{3-((4-methoxy-2-oxidobenzylidene)amino)-2-oxo-2H-chromen-4-olato-κ3O,N,O′}dimanganese(II), C38H38Mn2N2O14
  4. Crystal structure of catena-poly[diaqua-bis(μ2-2-(2-((2,6-dichlorophenyl)amino)phenyl)acetato-κ3O,O′:O′)calcium(II)], C56H48N4Ca2Cl8O12
  5. Crystal structure of catena-poly[triaqua-(isophthalato-κO)-(μ2-1,6-di(1H-imidazol-1-yl)hexane-κ2N:N′)]nickel(II), C20H28N4NiO7
  6. Crystal structure of cyclo[hexaqua-bis[1-[(2-ethyl-1H-imidazol-1-yl) methyl]-1H-benzotriazole-κ2N:N′]-bis(sulfato-κ1O)dicadmium(II)] monohydrate, C24H42Cd2N10O16S2
  7. Crystal Structure of bis(2-fluorbenzoato-κO)-bis(1,10-phenanthroline-κ2N,N′)manganese(II) dihydrate, C38H28F2MnN4O6
  8. Crystal structure of tetrapropylammonium 5-hydroxyisophthalate tetrahydrate, C20H41NO9
  9. Crystal structural of 2-amino-4-(3-bromophenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo[b]pyran, C18H17BrN2O2
  10. Crystal structural of 2-amino-4-(4-methoxyphenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C17H16N2O3
  11. Crystal structure of catena-poly[aqua(μ2-1,3-bis(1H-benzo[d]imidazol-1-yl)propane-κ2N:N′)-(μ2-5-(tert-butyl)isophthalate-κ3O,O′:O′′)nickel(II)], C29H30N4NiO5
  12. Crystal structure of catena-poly[(μ2-dicyanamido-κ2N:N′)-(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O′)copper(II)], C9H8CuN4O
  13. Crystal structure of bis(5,5′-((butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido-k4N,N′,N′′,N′′′)copper(II), C24H32CuN4O4
  14. The crystal structure of the formamide solvate of (17b)-estra-1,3,5(10)-triene-3,17diol, C19H27NO3
  15. Crystal structure of catena-poly[diaqua-bis(μ2-1H-benzo[d]imidazole-5-carboxylato-κ2N:O)nickel(II)] dihydrate, C16H18N4NiO8
  16. Crystal structure of dibromido[(1,2-bis(diisopropylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]nickel(II), C14H38B10NiBr2P2
  17. The crystal structure of catena-poly[aquachlorido(3,3′-([4,4′-bipyridine]-1,1′-diium-1,1′-diylbis(methylene))dibenzoato-κ2O:O′)copper(II)] chloride dihydrate, C26H26Cl2CuN2O7
  18. The crystal structure of N′-(2-nitrobenzylidene)-2-phenylacetohydrazide, C15H13N3O3
  19. Crystal structure of dichlorido bis[1-[(2-methyl-1H-benzoimidazol-1-yl)methyl]-1H-benzotriazole-κ1N]cadmium(II), C30H26CdCl2N10
  20. Crystal structure of aqua-bis(3-(2-pyridyl)-5-(4-pyridyl)-1H-1,2,4-triazole-κ2N,N′)copper(II) sulfate tetrahydrate, C24H28CuN10O9S
  21. Crystal structure of dibromido-carbonyl-(η6-p-cymene)osmium(II), C11H14Br2OOs
  22. Crystal structure of catena-poly[chlorido-(μ2-chlorido)-bis(imidazole-κN)copper(II)] C6H8Cl2CuN4
  23. Crystal structure of [(1,2-bis(dicyclohexylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]dibromidonickel(II)), C26H54B10NiBr2P2
  24. Crystal structure of dichlorido[1,1′-bis(diphenylphosphanyl)ferrocene-κ2P,P′]zinc(II), C34H28FeCl2P2Zn
  25. Crystal structure of tris(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O)-trithiocyanato-κN-dicobalt(III), C24H24Co2N6O3S3
  26. The crystal structure of diaqua-2,2′-((cyclohexane-1,2-diylbis(azanylylidene))bis(methanylylidene))diphenolato-κ4N,N′,O,O′)manganese(III) perchlorate, C20H24MnClN2O4
  27. Crystal structure of bis(μ3-chlorido)-bis(μ2-chlorido)-tetrakis(μ2-2,6-bis (diphenylmethyl)-4-t-butylphenolato)tetralithium(I)dicobalt(II) toluene solvate, C75.5H70Cl2CoLi2O2
  28. The crystal structure of hexaaqua-bis(μ2-3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κ2O:O′)-tetrakis(3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κO)dierbium(III) octahydrate, C60H76N18O32Er2
  29. Crystal structure of dimethylammonium bis(naphthalene-2,3-diolato)borate, C22H20BNO4
  30. Crystal structure of 2-amino-4-(4-nitro-phenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C18H17N3O4
  31. The crystal structure of (E)-4-chloro-2-(((5-methylpyridin-2-yl)imino)methyl)phenol, C13H11ClN2O
  32. Crystal structure of bis(N,N,N-trimethylbutanaminium) poly[heptaselenidotristannate(IV)], C14H36N2Se7Sn3
  33. The crystal structure of N-((3,5-di-tert-butyl-4-hydroxyphenyl)(phenyl)methyl)-4-methylbenzenesulfonamide, C28H35N3S
  34. Crystal structure of 2-(4-chlorophenyl)-2,3-dihydro-1H-perimidine, C17H13Cl1N2
  35. The Crystal structure of 2-iodo-1-(p-tolyl)propan-1-one, C10H11IO
  36. Crystal structure of ethyl 1-(4-bromobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17BrN2O2
  37. Crystal structure of ethyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17FN2O2
  38. Crystal structure of catena-poly[diaqua-(μ2-2,5-dihydroxyterephthalato-κ4O,O′:O′′,O′′′)cadmium(II)], C8H8O8Cd
  39. Crystal structure of tetraaqua-bis[6-(1H-imidazol-1-yl-κN)nicotinato]zinc(II), C18H20N6O8Zn
  40. Crystal structure of dichlorido-bis(N-phenyl-2-(quinolin-8-yloxy)acetamide-κ2N,O) – acetone (2/1), C35.5H31N4O4.5Cl2Cu
  41. Crystal Structure of ethyl (E)-3,4-dimethyl-5-((2-(4-methylbenzoyl)hydrazono)methyl)-1H-pyrrole-2-carboxylate — water — ethanol (1/1/1), C20H29N3O5
  42. Crystal structure of 5-((4-(1H-benzo[d]imidazol-2-yl)-2-methoxyphenoxy)methyl)-2-chlorothiazole - trichloromethane - methanol (1/1/1), C20H19Cl4N3O3S
  43. The crystal structure of a matrine derivative: 41S,7aS,12S,13aR,13bR)-12-(4-methylpiperazin-1-yl)dodecahydro-1H,5H,10H-dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one, C20H34N4O
  44. Crystal structure of cesium beryllophosphate, Be3Cs2P4O14
  45. Crystal Structure of 3-((3-hydroxybenzyl)ammonio)-3-phenylpropanoate, C16H17NO3
  46. Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride — 4-hydroxy-3-methoxybenzoic acid — water (2/1/5), C48H54N2Cl2O17
  47. The crystal structure of (1R, 2R)-N1,N2-diferrocenyl-1,2-cyclohexanedicarboxamide, C28H30Fe2N2O2
  48. Crystal structure of N-(2-methylphenyl)ethoxycarbothioamide, C10H13NOS
  49. Crystal Structure of ethyl (E)-2,4-dimethyl-5-((2-tosylhydrazono)methyl)-1H-pyrrole-3-carboxylate monohydrate, C17H23N3O5
  50. Crystal structure of Diiodo-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3N,N′,O)cadium(II) – dimethylformamide (1/1), C19H19N5O2CdI2
  51. Crystal structure of dinitrato-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3-N,N′,O)copper(II), C16H12N6O7Cu
  52. Crystal structure of benzoato-κO-bis(1,3,5-triaza-7-phosphaadamantane-κP)silver(I) monohydrate C19H31AgN6O3P2
  53. Crystal structure of (E)-2-(anthracen-9-ylmethylene)hydrazine-1-carbothioamide, C16H13N3S
  54. The crystal structure of 8-chloro-7-ethyl-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione, C9H11ClN4O2
  55. Crystal structure of {5,5′-((propane-1,3-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido)-κ4N,N′,N′′,N′′′}zinc(II), C23H30N4O4Cu
  56. Crystal structure of bis(4-dimethylamino-pyridin-1-ium)tetrafluorosuccinate, C18H22F4N4O4
  57. Crystal structure of dimethyl 3,9-dibenzyl-6,12-dicyclohexyl-3,9-diazahexacyclo [6.4.0.02,7.04,11.05,10]-dodecane-1,11-dicarboxylate, C40H50N2O4
  58. Crystal structure of diethyl 3,9-diphenyl-6,12-bis(3-methoxyphenyl)-3,9-diazahexacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,11-dicarboxylate, C42H42N2O6
  59. Crystal structure of bis(acetato-κO)-bis(1-(pyridin-2-yl)ethan-1-one oxime-κ2N,N′)nickel(II), C18H22N4NiO6
  60. Crystal structure of (N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3N,O,O′)-diphenyltin(IV), C28H23FN2O3Sn
  61. Crystal structure of {N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3O,N,O′}dimethyltin(IV), C18H19FN2O3Sn
Heruntergeladen am 3.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2017-0279/html?lang=de
Button zum nach oben scrollen